Tuberous Sclerosis Complex (TSC), is a neurocutaneous disorder, associated with a high
prevalence of autism spectrum disorder (ASD; ~50%). Understanding language development …

The Food and Drug Administration (FDA) has approved two mechanism-based treatments
for tuberous sclerosis complex (TSC)-everolimus and vigabatrin. However, these treatments …

Objective. To review the recent literature on the clinical features, genetic mutations, neurobiology
associated with dysregulation of mTOR (mammalian target of rapamycin), and clinical …

Tuberous sclerosis complex (TSC) is a multi-system disorder resulting from mutations in
either the TSC1 or TSC2 genes leading to hyperactivation of mechanistic target of rapamycin (…

BACKGROUND AND PURPOSE Tuberous sclerosis complex (TSC) is a rare, genetic
disease that is associated with multiple manifestations including epilepsy and autism. Self‐…

… Author links open overlay panel Tanjala T. Gipson MD a b c d , Gwendolyn Gerner PsyD
a b c , Siddharth Srivastava MD b , Andrea Poretti MD g , Rebecca Vaurio PhD h i , Adam …

Aims. This study explores disparities in identification of educationally relevant comorbidities
and medication prescribing practices for children with attention-deficit hyperactivity disorder (…

Background Our goal was to assess for the first time early vocalizations as precursors to speech
in audio-video recordings of infants with tuberous sclerosis complex (TSC). Methods We …

Tuberous sclerosis complex is a multisystem, chronic genetic condition characterized by
systemic growth of benign tumors and often accompanied by epilepsy, autism spectrum …

Background Tuberous sclerosis complex (TSC) is associated with a wide range of physical
manifestations for which international clinical recommendations for diagnosis and …